Hemophilia Treatment Market Poised for a Robust 5.2% CAGR for Between 2022-2027
Hemophilia is a rare recessive bleeding disorder that poses difficulties in blood clotting. Although it is prevalent in relatively smaller population size, the incidence of hemophilia has surged significantly in recent years. As a result, government institutions and international health agencies are driven to embrace novel procedures and techniques to treat hemophilia. In addition to developing...
0 Kommentare
0 Anteile